Skip to main content
. 2021 Dec 2;2(12):100466. doi: 10.1016/j.xcrm.2021.100466

Table 1.

Inclusion and exclusion criteria

Inclusion criteria
Men and non-pregnant women
Diagnosis of T1D for a minimum of 5 years
Hypoglycemia unawareness (Clarke score) or significant glycemic lability
Stable diabetic treatment
Willingness to use a continuous glucose meter
Acceptable candidate for surgical implantation

Exclusion criteria

History of islet cell, kidney, and/or pancreas transplant
Six or more severe, unexplained hypoglycemic events within 6 months of enrollment
Uncontrolled or untreated thyroid disease or adrenal insufficiency
Diabetic complications such as severe kidney disease or renal dysfunction, proliferative retinopathy, foot ulcers, amputations, and/or severe peripheral neuropathy
Detectable stimulated serum C-peptide during the screening perioda
a

C-peptide was assessed at two separate screening visits.